INLET BEACH, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Spectrum Spine Inc is pleased to announce U.S. FDA clearance of its lumbar family of cage implants. These devices incorporate BioBraille surface treatment on the bone contact areas and the interior of the graft window. The family includes PLIF/TLIF, Oblique TLIF, DLIF and ALIF procedural solutions. An ultra … [Read more...] about Spectrum Spine Inc Clears US FDA with Family of Lumbar Interbody Cages with BioBraille
NEWS
Centinel Spine® prodisc® Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record
WEST CHESTER, Pa., July 22, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of nearly $33 … [Read more...] about Centinel Spine® prodisc® Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record
SurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™
ShareBOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec® has received additional FDA 510(k) clearance for OsteoFlo® HydroFiber™, its advanced synthetic bone graft, marking another key regulatory milestone. This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant … [Read more...] about SurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™
Globus Medical: What’s Behind the Surprise Exit of CEO Dan Scavilla?
The sudden departure of Dan Scavilla as CEO of Globus Medical has caught many investors and analysts off guard. While the company hasn’t publicly acknowledged any internal conflicts, the broader context suggests a mix of personal career opportunity and potential strategic differences at the top levels of leadership. Official Reason: An Irresistible Offer Scavilla will be … [Read more...] about Globus Medical: What’s Behind the Surprise Exit of CEO Dan Scavilla?
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer effective July 18, 2025. Daniel … [Read more...] about Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
Why Are Medical Device Giants Exiting or Losing Interest in the Spine Market?
In the early 2000s, spinal implants were one of the most exciting and fastest-growing segments in the medical device industry. Advances in surgical techniques, biomaterials, and imaging led to a wave of innovation that promised to transform spinal care. Technologies for spinal fusion, disc replacement, and minimally invasive procedures opened new possibilities for both surgeons … [Read more...] about Why Are Medical Device Giants Exiting or Losing Interest in the Spine Market?
Dr. Stephen Courtney Performs World’s First Procedure Using Eminent Spine’s Groundbreaking 3D-Printed Pedicle Screw
Plano, TX, July 16, 2025 --(PR.com)-- Eminent Spine, a leading innovator in spinal implant technologies, is proud to announce a major surgical milestone: Dr. Stephen Courtney has successfully completed the world’s first spinal procedure using the company’s revolutionary 3D-printed pedicle screw system. This groundbreaking case marks a new era in spinal surgery, combining … [Read more...] about Dr. Stephen Courtney Performs World’s First Procedure Using Eminent Spine’s Groundbreaking 3D-Printed Pedicle Screw
SpineGuard obtains US patent on DSG-enabled active safety stopfor hand-held bone drilling power tools in free-hand,navigated or robotically-assisted surgery
PARIS and BOULDER (CO), July 16, 2025 – 6:00 pm CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced that its patent application directed to enhance safety of bone drilling power tools thanks to a DSG-enabled … [Read more...] about SpineGuard obtains US patent on DSG-enabled active safety stopfor hand-held bone drilling power tools in free-hand,navigated or robotically-assisted surgery
Carlsmed Announces Launch of Initial Public Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the launch of its initial public offering of 6,700,000 shares of common stock. In addition, the underwriters will have a 30-day option to purchase up to 1,005,000 additional shares of common … [Read more...] about Carlsmed Announces Launch of Initial Public Offering
IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced that its innovative JAZZ range has been approved by the CFDA in China. As part of a distribution … [Read more...] about IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China
Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and … [Read more...] about Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
SurGenTec® Launches INSITE™ Sterile Surgery-Ready Kit with Implant and Instruments for SI Joint Fusion
BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a leading innovator in minimally invasive orthopedic and spine surgery solutions, is proud to announce the launch of its new TiLINK®-INSITE™ Sacroiliac Joint Fusion System. The system—now available in a sterile, surgery-ready kit—has already been successfully utilized in initial procedures performed across multiple U.S. sites, … [Read more...] about SurGenTec® Launches INSITE™ Sterile Surgery-Ready Kit with Implant and Instruments for SI Joint Fusion
Wenzel Spine Receives FDA Clearance for First Expandable Sacroiliac (SI) Fusion Implant, panaSIa™
AUSTIN, Texas--(BUSINESS WIRE)--Wenzel Spine, Inc., a medical technology company focused on minimally invasive surgical and analytic solutions for spinal disorders, today announced it has received FDA clearance for its revolutionary expandable sacroiliac (SI) fusion implant, panaSIa. This milestone marks the first ever FDA clearance of an expandable SI fusion implant, … [Read more...] about Wenzel Spine Receives FDA Clearance for First Expandable Sacroiliac (SI) Fusion Implant, panaSIa™
Is Medtronic Back on Track After a Solid Q2 – and in Spine?
Medtronic plc (NYSE: MDT), a global leader in medical technology, recently released its financial results for the second quarter of fiscal year 2025, which ended on April 30, 2025. This analysis covers the company’s overall performance, with a special focus on the Spine segment (Cranial & Spinal Technologies - CST), as well as market expectations and the impact on its stock … [Read more...] about Is Medtronic Back on Track After a Solid Q2 – and in Spine?
Dymicron Granted IDE Approval for Triadyme-C Artificial Disc
OREM, Utah, July 10, 2025 /PRNewswire/ -- Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme®–C cervical artificial disc. This … [Read more...] about Dymicron Granted IDE Approval for Triadyme-C Artificial Disc
The Quiet Return of the Viscogliosi Brothers to Spine Leadership
At a time when several large medtech companies are stepping back from the spine market, the Viscogliosi brothers — pioneers, investors, and key architects behind some of the most relevant spine innovations of the past two decades — are quietly executing a bold consolidation strategy that deserves closer attention. From Pioneers to Strategic Builders Marc, John, and … [Read more...] about The Quiet Return of the Viscogliosi Brothers to Spine Leadership
Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
CARLSBAD, CALIFORNIA, July 09, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced initial surgeries using Aurora Spine’s newest product, the AERO™ Lumbar Fusion System, have commenced. The minimally invasive procedures … [Read more...] about Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
SPINEMarketGroup Celebrates 16 Years Supporting the Spine Industry Community
Launched in July 2009, SPINEMarketGroup is proud to celebrate its 16th anniversary this month, reaffirming our ongoing commitment to the global community of professionals working in the spine industry. From the very beginning, our mission has been clear: to support the spine community by consistently providing relevant information about market trends, products, and the … [Read more...] about SPINEMarketGroup Celebrates 16 Years Supporting the Spine Industry Community
Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery
SAN LUIS OBISPO, Calif., July 8, 2025 /PRNewswire/ -- Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification and marketing authorization for Oxiplex® gel, indicated for reducing postoperative leg pain … [Read more...] about Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery